机译:Key questions regarding the SYMPLICITY HTN-3 trial
Institute for Clinical Medicine University of Oslo;
Faculty of Biology and Medicine University of Lausanne;
Department of Hypertension and Diabetology Medical University of GdanskInstitute of Clinical Pharmacology and Toxicology Charité–Universit?tsmedizin BerlinUniversity of Milano-Bicocca;